Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
about
News coverage of FDA warnings on pediatric antidepressant use and suicidalityChanges in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental studyThe FDA And ABCs: Unintended Consequences Of Antidepressant Warnings On Human Capital.Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)Antidepressant drugs and the risk of suicide in children and adolescents.Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.Primary care physician attitudes and perceptions of the impact of FDA-proposed REMS policy on prescription of extended-release and long-acting opioids.Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box WarningA critical review of methods to evaluate the impact of FDA regulatory actions.ADHD medication use following FDA risk warnings.The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.An update on antidepressant use and suicidality in pediatric depression.Long-Run Trends in Antidepressant Use Among Youths After the FDA Black Box Warning.A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis.
P2860
Q33584737-F11CE982-E249-44EF-B3A7-88B40A34E7A1Q33774659-89960B99-A3F5-49D4-9F49-17DF796F8E15Q34275043-1446A165-8E0C-4E53-A543-3AAE96142954Q34389980-7BEDB422-5D75-4945-988C-CCE0429D034DQ34399552-10B29002-B822-4102-935A-70F5A891FC0EQ35928690-84607F2D-1B5A-462B-BA20-F11070D7A3C0Q36326428-ACA02510-D276-4F2B-8A98-28AE10AF798FQ37275848-04A77BC2-B71E-4CB1-9B64-E9FC0C7BC9F1Q37301216-9F9848E8-010B-40E0-BE41-00E7D839F42CQ37497927-F1E800C2-B45B-43E4-A007-D4CD81F5DDF0Q37683523-7C33092F-63F2-4FA6-B60C-88BC3CBDEA93Q38044018-82A937A4-13C2-46B3-827C-B39C0CD5DC12Q47309145-C13238A1-1EA1-4C5C-B358-FA8E35FDC142Q47609958-8122D310-58BD-45C1-BFC9-1AE7DF5F6E06Q47653552-4D6DD56A-B60B-46A7-BC47-9883587FF134Q48075180-68EC8407-1075-4849-8BB7-296BC4E939AAQ53414337-5453D049-C6EB-4438-A1B8-E4C8241B36BC
P2860
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@ast
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@en
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@nl
type
label
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@ast
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@en
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@nl
prefLabel
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@ast
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@en
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@nl
P2093
P2860
P921
P356
P1433
P1476
Antidepressants and suicide ri ...... ngs affect treatment patterns?
@en
P2093
Andrés Martin
Colleen L Barry
Douglas L Leslie
Erika G Martin
Richard G Frank
Susan H Busch
P2860
P356
10.1176/PS.2010.61.1.11
P577
2010-01-01T00:00:00Z